Cargando…
Diagnostics and Therapeutics in Targeting HER2 Breast Cancer: A Novel Approach
Breast cancer is one of the most commonly occurring cancers in women globally and is the primary cause of cancer mortality in females. BC is highly heterogeneous with various phenotypic expressions. The overexpression of HER2 is responsible for 15–30% of all invasive BC and is strongly associated wi...
Autores principales: | Vi, Chris, Mandarano, Giovanni, Shigdar, Sarah |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8201268/ https://www.ncbi.nlm.nih.gov/pubmed/34200484 http://dx.doi.org/10.3390/ijms22116163 |
Ejemplares similares
-
Radiolabelled Aptamers for Theranostic Treatment of Cancer
por: Khalid, Umair, et al.
Publicado: (2018) -
Aptamer-Based Diagnostics and Therapeutics
por: Shigdar, Sarah
Publicado: (2019) -
HER2 Inhibition in Gastric Cancer—Novel Therapeutic Approaches for an Established Target
por: Fong, Caroline, et al.
Publicado: (2022) -
Novel approaches to target HER2-positive breast cancer: trastuzumab emtansine
por: Recondo, Gonzalo, et al.
Publicado: (2016) -
HER-2/neu diagnostics in breast cancer
por: Carney, Walter P, et al.
Publicado: (2007)